AXCELIS TECHNOLOGIES INC (ACLS)

US0545402085 - Common Stock

73.28  +2.28 (+3.21%)

After market: 73.35 +0.07 (+0.1%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ACLS. ACLS was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS gets an excellent profitability rating and is at the same time showing great financial health properties. ACLS is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, ACLS could be worth investigating further for value and quality investing!.



8

1. Profitability

1.1 Basic Checks

In the past year ACLS was profitable.
ACLS had a positive operating cash flow in the past year.
In the past 5 years ACLS has always been profitable.
Of the past 5 years ACLS 4 years had a positive operating cash flow.

1.2 Ratios

ACLS has a better Return On Assets (18.58%) than 92.59% of its industry peers.
With an excellent Return On Equity value of 25.61%, ACLS belongs to the best of the industry, outperforming 89.81% of the companies in the same industry.
ACLS's Return On Invested Capital of 22.14% is amongst the best of the industry. ACLS outperforms 93.52% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACLS is significantly above the industry average of 11.05%.
Industry RankSector Rank
ROA 18.58%
ROE 25.61%
ROIC 22.14%
ROA(3y)16.79%
ROA(5y)12.3%
ROE(3y)24.74%
ROE(5y)17.73%
ROIC(3y)22.37%
ROIC(5y)16.23%

1.3 Margins

ACLS has a better Profit Margin (21.54%) than 80.56% of its industry peers.
In the last couple of years the Profit Margin of ACLS has grown nicely.
Looking at the Operating Margin, with a value of 23.40%, ACLS belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
In the last couple of years the Operating Margin of ACLS has grown nicely.
With a Gross Margin value of 44.63%, ACLS perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.4%
PM (TTM) 21.54%
GM 44.63%
OM growth 3Y24.37%
OM growth 5Y11.64%
PM growth 3Y27.39%
PM growth 5Y16%
GM growth 3Y1.27%
GM growth 5Y1.38%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ACLS is still creating some value.
ACLS has less shares outstanding than it did 1 year ago.
ACLS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACLS has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 6.66 indicates that ACLS is not in any danger for bankruptcy at the moment.
ACLS's Altman-Z score of 6.66 is fine compared to the rest of the industry. ACLS outperforms 71.30% of its industry peers.
The Debt to FCF ratio of ACLS is 0.29, which is an excellent value as it means it would take ACLS, only 0.29 years of fcf income to pay off all of its debts.
ACLS has a better Debt to FCF ratio (0.29) than 84.26% of its industry peers.
ACLS has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
ACLS has a better Debt to Equity ratio (0.05) than 60.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.29
Altman-Z 6.66
ROIC/WACC1.49
WACC14.84%

2.3 Liquidity

ACLS has a Current Ratio of 4.42. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.42, ACLS is in the better half of the industry, outperforming 68.52% of the companies in the same industry.
ACLS has a Quick Ratio of 3.26. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.26, ACLS is doing good in the industry, outperforming 65.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.42
Quick Ratio 3.26

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased by -3.29% in the last year.
The Earnings Per Share has been growing by 40.65% on average over the past years. This is a very strong growth
Looking at the last year, ACLS shows a very strong growth in Revenue. The Revenue has grown by 22.89%.
Measured over the past years, ACLS shows a very strong growth in Revenue. The Revenue has been growing by 20.63% on average per year.
EPS 1Y (TTM)-3.29%
EPS 3Y76.12%
EPS 5Y40.65%
EPS Q2Q%-25.13%
Revenue 1Y (TTM)22.89%
Revenue growth 3Y33.56%
Revenue growth 5Y20.63%
Sales Q2Q%-12.23%

3.2 Future

The Earnings Per Share is expected to grow by 4.74% on average over the next years.
Based on estimates for the next years, ACLS will show a small growth in Revenue. The Revenue will grow by 3.66% on average per year.
EPS Next Y-17.38%
EPS Next 2Y-2.31%
EPS Next 3Y4.74%
EPS Next 5YN/A
Revenue Next Year-8.76%
Revenue Next 2Y-1.9%
Revenue Next 3Y3.66%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.84, the valuation of ACLS can be described as reasonable.
Based on the Price/Earnings ratio, ACLS is valued cheaply inside the industry as 95.37% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.96. ACLS is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 10.33, the valuation of ACLS can be described as reasonable.
Based on the Price/Forward Earnings ratio, ACLS is valued cheaply inside the industry as 97.22% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.82. ACLS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.84
Fwd PE 10.33

4.2 Price Multiples

95.37% of the companies in the same industry are more expensive than ACLS, based on the Enterprise Value to EBITDA ratio.
92.59% of the companies in the same industry are more expensive than ACLS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.59
EV/EBITDA 5.1

4.3 Compensation for Growth

The excellent profitability rating of ACLS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2Y-2.31%
EPS Next 3Y4.74%

0

5. Dividend

5.1 Amount

ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (11/21/2024, 8:10:36 PM)

After market: 73.35 +0.07 (+0.1%)

73.28

+2.28 (+3.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.38B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 10.84
Fwd PE 10.33
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.27
Profitability
Industry RankSector Rank
ROA 18.58%
ROE 25.61%
ROCE
ROIC
ROICexc
ROICexgc
OM 23.4%
PM (TTM) 21.54%
GM 44.63%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.42
Quick Ratio 3.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-3.29%
EPS 3Y76.12%
EPS 5Y
EPS Q2Q%
EPS Next Y-17.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)22.89%
Revenue growth 3Y33.56%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y